Open-label, Multicenter, Randomized, Parallel Study to Investigate pk, pd, Efficacy and Safety of Tocilizumab (TCZ, RO4877533) Following Subcutaneous Administration of TCZ 162 mg Weekly or Every Other Week in Combination With Methotrexate in Patients With Rheumatoid Arthritis.
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Tocilizumab (Primary) ; Folic acid; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Roche
Most Recent Events
- 19 Sep 2011 Actual end date (August 2011) added as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2011 Planned end date changed from 1 Aug 2011 to 1 Oct 2011 reported by ClinicalTrials.gov.